UBS Group’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-73,072
| Closed | -$113K | – | 11529 |
|
|
2021
Q4 | $113K | Buy |
73,072
+49,281
| +207% | +$81.3K | ﹤0.01% | 6206 |
|
|
2021
Q3 | $37K | Buy |
23,791
+3,291
| +16% | +$6.45K | ﹤0.01% | 6585 |
|
|
2021
Q2 | $54K | Hold |
20,500
| – | – | ﹤0.01% | 6370 |
|
|
2021
Q1 | $31K | Hold |
20,500
| – | – | ﹤0.01% | 7001 |
|
|
2020
Q4 | $27K | Sell |
20,500
-1,500
| -7% | -$1.69K | ﹤0.01% | 6735 |
|
|
2020
Q3 | $25K | Sell |
22,000
-2,300
| -9% | -$2.53K | ﹤0.01% | 6144 |
|
|
2020
Q2 | $20K | Sell |
24,300
-60,462
| -71% | -$44.9K | ﹤0.01% | 6577 |
|
|
2020
Q1 | $61K | Sell |
84,762
-100,791
| -54% | -$112K | ﹤0.01% | 5671 |
|
|
2019
Q4 | $247K | Buy |
185,553
+62,605
| +51% | +$87.3K | ﹤0.01% | 5449 |
|
|
2019
Q3 | $173K | Buy |
122,948
+40,700
| +49% | +$81.1K | ﹤0.01% | 5361 |
|
|
2019
Q2 | $266K | Buy |
82,248
+15,651
| +24% | +$53.9K | ﹤0.01% | 4730 |
|
|
2019
Q1 | $249K | Sell |
66,597
-29,175
| -30% | -$92.6K | ﹤0.01% | 4484 |
|
|
2018
Q4 | $208K | Buy |
95,772
+17,969
| +23% | +$44.6K | ﹤0.01% | 4929 |
|
|
2018
Q3 | $210K | Buy |
77,803
+29,288
| +60% | +$103K | ﹤0.01% | 5020 |
|
|
2018
Q2 | $206K | Sell |
48,515
-2,217
| -4% | -$8.33K | ﹤0.01% | 4922 |
|
|
2018
Q1 | $186K | Sell |
50,732
-6,951
| -12% | -$25.8K | ﹤0.01% | 4831 |
|
|
2017
Q4 | $216K | Sell |
57,683
-10,351
| -15% | -$41.4K | ﹤0.01% | 4854 |
|
|
2017
Q3 | $293K | Sell |
68,034
-5,566
| -8% | -$22.9K | ﹤0.01% | 4585 |
|
|
2017
Q2 | $305K | Sell |
73,600
-8,333
| -10% | -$32.5K | ﹤0.01% | 4475 |
|
|
2017
Q1 | $299K | Sell |
81,933
-9,542
| -10% | -$33.5K | ﹤0.01% | 4389 |
|
|
2016
Q4 | $453K | Sell |
91,475
-1,180
| -1% | -$5.35K | ﹤0.01% | 4203 |
|
|
2016
Q3 | $386K | Sell |
92,655
-6,585
| -7% | -$26.9K | ﹤0.01% | 4089 |
|
|
2016
Q2 | $393K | Buy |
99,240
+12,040
| +14% | +$47.2K | ﹤0.01% | 4080 |
|
|
2016
Q1 | $291K | Buy |
87,200
+22,830
| +35% | +$75K | ﹤0.01% | 4208 |
|
|
2015
Q4 | $275K | Buy |
64,370
+28,221
| +78% | +$121K | ﹤0.01% | 4425 |
|
|
2015
Q3 | $152K | Buy |
36,149
+1,649
| +5% | +$10.4K | ﹤0.01% | 4862 |
|
|
2015
Q2 | $281K | Sell |
34,500
-4,260
| -11% | -$35.5K | ﹤0.01% | 4574 |
|
|
2015
Q1 | $301K | Buy |
38,760
+33,131
| +589% | +$284K | ﹤0.01% | 4555 |
|
|
2014
Q4 | $66K | Buy |
+5,629
| New | +$67.2K | ﹤0.01% | 6153 |
|
UBS Group's CSLT Position: Q1 2022 in Review
UBS Group sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 73,072 shares — an estimated $113K sold.
UBS Group first reported a position in CSLT in Q4 2014 and held it in 29 quarters. The position peaked at $453K in Q4 2016. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.
- UBS Group reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
- UBS Group sold 73,072 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $113K.
- UBS Group first reported a position in CASTLIGHT HEALTH, INC. in Q4 2014 and held it in 29 quarters.
- UBS Group's CASTLIGHT HEALTH, INC. position peaked at $453K in Q4 2016.
- 0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.
Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.